Your browser doesn't support javascript.
loading
Highly sensitive detection of Epstein-Barr virus-infected cells by EBER flow FISH.
Tomomasa, Dan; Tanita, Kay; Hiruma, Yuriko; Hoshino, Akihiro; Kudo, Ko; Azumi, Shohei; Shiota, Mitsutaka; Yamaoka, Masayoshi; Eguchi, Katsuhide; Ishimura, Masataka; Tanaka, Yuka; Iwatsuki, Keiji; Okuno, Keisuke; Hama, Asahito; Sakamoto, Ken-Ichi; Taga, Takashi; Goto, Kimitoshi; Ota, Haruka; Ichiki, Akihiro; Kanda, Kaori; Miyamura, Takako; Endo, Saori; Ohnishi, Hidenori; Sasahara, Yoji; Arai, Ayako; Fornier, Benjamin; Imadome, Ken-Ichi; Morio, Tomohiro; Latour, Sylvain; Kanegane, Hirokazu.
Afiliación
  • Tomomasa D; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Tanita K; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Hiruma Y; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, UMR 1163, INSERM, Imagine Institute, Paris, France.
  • Hoshino A; Faculty of Medicine, Tokyo Medical and Dental University (TMUD), Tokyo, Japan.
  • Kudo K; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, UMR 1163, INSERM, Imagine Institute, Paris, France. nrb52665@yahoo.co.jp.
  • Azumi S; Deparment of Child Health and Development, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-Ku, Tokyo, 113-8519, Japan. nrb52665@yahoo.co.jp.
  • Shiota M; Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Yamaoka M; Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan.
  • Eguchi K; Department of Pediatrics, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai, Osaka, Japan.
  • Ishimura M; Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan.
  • Tanaka Y; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Iwatsuki K; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Okuno K; Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Hama A; Department of Dermatology, Okayama University Graduate School of Medicine, Okayama, Japan.
  • Sakamoto KI; Division of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, Yonago, Japan.
  • Taga T; Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Nagoya, Japan.
  • Goto K; Department of Pediatrics, Shiga University of Medical Science, Shiga, Japan.
  • Ota H; Department of Pediatrics, Shiga University of Medical Science, Shiga, Japan.
  • Ichiki A; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan.
  • Kanda K; Department of Virology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Miyamura T; Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
  • Endo S; Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
  • Ohnishi H; Department of Pediatrics, Gifu Municipal Hospital, Gifu, Japan.
  • Sasahara Y; Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Arai A; Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.
  • Fornier B; Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.
  • Imadome KI; Department of Pediatrics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Morio T; Department of Hematology and Oncology, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Latour S; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, UMR 1163, INSERM, Imagine Institute, Paris, France.
  • Kanegane H; Paediatric Haematology-Immunology and Rheumatology Unit, Necker Hospital, AP-HP.Centre - Université Paris Cité, Paris, France.
Int J Hematol ; 2024 May 03.
Article en En | MEDLINE | ID: mdl-38700651
ABSTRACT
When Epstein-Barr virus (EBV) infection is suspected, identification of infected cells is important to understand the pathogenesis, determinine the treatment strategy, and predict the prognosis. We used the PrimeFlow™ RNA Assay Kit with a probe to detect EBV-encoded small RNAs (EBERs) and multiple surface markers, to identify EBV-infected cells by flow cytometry. We analyzed a total of 24 patients [11 with chronic active EBV disease (CAEBV), 3 with hydroa vacciniforme lymphoproliferative disorder, 2 with X-linked lymphoproliferative disease type 1 (XLP1), 2 with EBV-associated hemophagocytic lymphohistiocytosis, and 6 with posttransplant lymphoproliferative disorder (PTLD)]. We compared infected cells using conventional quantitative PCR methods and confirmed that infected cell types were identical in most patients. Patients with CAEBV had widespread infection in T and NK cells, but a small amount of B cells were also infected, and infection in patients with XLP1 and PTLD was not limited to B cells. EBV-associated diseases are believed to be complex pathologies caused by EBV infecting a variety of cells other than B cells. We also demonstrated that infected cells were positive for HLA-DR in patients with CAEBV. EBER flow FISH can identify EBV-infected cells with high sensitivity and is useful for elucidating the pathogenesis.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Japón
...